LENZ Therapeutics, Inc. (LENZ)

Latest Insider Confidence Score

2026Q1

47.7
Bearish

Company insider confidence (by quarter)

2021Q2 2026Q1

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
EcoR1 Capital, LLC — 8,538,446 Jan 6, 2023
Alpha Wave Global, LP — 3,612,211 Mar 28, 2024
Alpha Wave Ventures GP, Ltd — 3,612,211 Mar 28, 2024
Lunate Holding RSC Ltd — 3,612,211 Mar 28, 2024
Chimera Investment LLC — 3,612,211 Mar 28, 2024

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jan 2, 2026 Jan 6, 2026 Olsson Shawn Chief Commercial Officer Neutral 52.5 - 0.00% ✗ -
Jan 2, 2026 Jan 6, 2026 Odrich Marc Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Jan 2, 2026 Jan 6, 2026 Chevallard Daniel R. CFO Neutral 52.5 - 0.00% ✗ -
Jan 2, 2026 Jan 6, 2026 Schimmelpennink Evert B. CEO Neutral 52.5 - 0.00% ✗ -
Nov 17, 2025 Nov 19, 2025 Olsson Shawn Chief Commercial Officer Sell 7.5 -10,000 -67.87% ✓ $261K
Nov 7, 2025 Nov 10, 2025 MCCOLLUM JAMES W Director Buy 82.5 +10,500 1.69% ✗ $239.3K
Nov 7, 2025 Nov 7, 2025 Chevallard Daniel R. CFO Buy 95.0 +2,198 68.95% ✗ $50K
Sep 30, 2025 Oct 2, 2025 Versant Venture Capital VI, L.P. 10% Owner Sell 15.0 -224,974 -11.03% ✗ $10.4M
Sep 18, 2025 Sep 22, 2025 Versant Venture Capital VI, L.P. 10% Owner Sell 16.3 -135,304 -6.22% ✗ $5.7M
Aug 22, 2025 Aug 26, 2025 Versant Venture Capital VI, L.P. 10% Owner Sell 16.3 -188,094 -7.96% ✗ $7.4M
Aug 15, 2025 Aug 19, 2025 Versant Venture Capital VI, L.P. 10% Owner Sell 15.0 -260,713 -9.94% ✗ $10.3M
Jul 10, 2025 Jul 14, 2025 Versant Venture Capital VI, L.P. 10% Owner Sell 16.3 -191,376 -5.23% ✗ $6.5M
Jun 27, 2025 Jul 1, 2025 Versant Venture Capital VI, L.P. 10% Owner Sell 16.3 -200,000 -5.18% ✗ $6.1M
Jun 18, 2025 Jun 20, 2025 Versant Venture Capital VI, L.P. 10% Owner Sell 15.0 -334,801 -9.99% ✗ $10.1M
Jun 10, 2025 Jun 12, 2025 Versant Venture Capital VI, L.P. 10% Owner Sell 15.0 -350,000 -9.46% ✗ $10.2M
Jun 11, 2025 Jun 11, 2025 RA CAPITAL MANAGEMENT, L.P. Director Neutral 52.5 - 0.00% ✗ -
Jun 11, 2025 Jun 11, 2025 George Jeffrey P. Director Neutral 52.5 - 0.00% ✗ -
Jun 11, 2025 Jun 11, 2025 Drapkin Kimberlee C Director Neutral 52.5 - 0.00% ✗ -
Jun 11, 2025 Jun 11, 2025 Guerard Frederic Director Neutral 52.5 - 0.00% ✗ -
Jun 11, 2025 Jun 11, 2025 Thunen Shelley B Director Neutral 52.5 - 0.00% ✗ -
Jun 11, 2025 Jun 11, 2025 MCCOLLUM JAMES W Director Neutral 52.5 - 0.00% ✗ -
Jun 11, 2025 Jun 11, 2025 Scheiner Zachary Director Neutral 52.5 - 0.00% ✗ -
Apr 9, 2025 Apr 9, 2025 Olsson Shawn Chief Commercial Officer Neutral 52.5 - 0.00% ✗ -
Mar 7, 2025 Mar 7, 2025 Schimmelpennink Evert B. CEO Neutral 52.5 - 0.00% ✗ -
Jan 9, 2025 Jan 13, 2025 Olsson Shawn Chief Commercial Officer Neutral 52.5 - 0.00% ✗ -
Jan 9, 2025 Jan 13, 2025 Odrich Marc Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Jan 9, 2025 Jan 13, 2025 Chevallard Daniel R. CFO Neutral 52.5 - 0.00% ✗ -
Jan 9, 2025 Jan 13, 2025 Schimmelpennink Evert B. CEO Neutral 52.5 - 0.00% ✗ -
Dec 16, 2024 Dec 17, 2024 Olsson Shawn Chief Commercial Officer Neutral 52.5 - 0.00% ✗ -
Jul 22, 2024 Jul 23, 2024 Schimmelpennink Evert B. CEO Neutral 52.5 - 0.00% ✗ -
May 14, 2024 May 15, 2024 Chevallard Daniel R. CFO Buy 91.3 +3,188 100.00% ✗ $50K
May 13, 2024 May 14, 2024 MCCOLLUM JAMES W Director Buy 92.5 +31,332 5.32% ✗ $501.1K
Mar 28, 2024 Alpha Wave Ventures GP, Ltd 10% Owner Neutral 52.5 - 0.00% ✗ -
Mar 21, 2024 Mar 25, 2024 RA CAPITAL MANAGEMENT, L.P. Director Buy 100.0 +4,243,794 140.71% ✗ $15M
Mar 25, 2024 RA CAPITAL MANAGEMENT, L.P. Director Neutral 52.5 - 0.00% ✗ -
Mar 21, 2024 Mar 25, 2024 Thunen Shelley B Director Neutral 52.5 - 0.00% ✗ -
Mar 21, 2024 Mar 25, 2024 MCCOLLUM JAMES W Director Neutral 90.0 +589,267 100.00% ✗ -
Mar 21, 2024 Mar 25, 2024 Guerard Frederic Director Neutral 52.5 - 0.00% ✗ -
Mar 21, 2024 Mar 25, 2024 Scheiner Zachary Director Neutral 52.5 - 0.00% ✗ -
Mar 21, 2024 Mar 25, 2024 Drapkin Kimberlee C Director Neutral 52.5 - 0.00% ✗ -
Mar 25, 2024 Scheiner Zachary Director Neutral 52.5 - 0.00% ✗ -
Mar 21, 2024 Mar 25, 2024 George Jeffrey P. Director Neutral 52.5 - 0.00% ✗ -
Mar 21, 2024 Mar 25, 2024 Chevallard Daniel R. CFO Neutral 52.5 - 0.00% ✗ -
Mar 21, 2024 Mar 25, 2024 Olsson Shawn Chief Commercial Officer Neutral 52.5 - 0.00% ✗ -
Mar 21, 2024 Mar 25, 2024 Odrich Marc Chief Medical Officer Neutral 90.0 +99,599 100.00% ✗ -
Mar 21, 2024 Mar 25, 2024 Schimmelpennink Evert B. CEO Neutral 52.5 - 0.00% ✗ -
Mar 25, 2024 Thunen Shelley B Director Neutral 52.5 - 0.00% ✗ -
Mar 25, 2024 MCCOLLUM JAMES W Director Neutral 52.5 - 0.00% ✗ -
Mar 25, 2024 Guerard Frederic Director Neutral 52.5 - 0.00% ✗ -
Mar 25, 2024 George Jeffrey P. Director Neutral 52.5 - 0.00% ✗ -
Mar 25, 2024 Chevallard Daniel R. CFO Neutral 52.5 - 0.00% ✗ -
Mar 25, 2024 Olsson Shawn Chief Commercial Officer Neutral 52.5 - 0.00% ✗ -
Mar 25, 2024 Odrich Marc Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Mar 25, 2024 Schimmelpennink Evert B. CEO Neutral 52.5 - 0.00% ✗ -
Mar 21, 2024 Mar 25, 2024 Versant Venture Capital VI, L.P. 10% Owner Neutral 90.0 +598,203 25.51% ✗ -
Mar 25, 2024 Versant Venture Capital VII, L.P. 10% Owner Neutral 52.5 - 0.00% ✗ -
Jul 28, 2023 Aug 1, 2023 Drapkin Kimberlee C Director Neutral 52.5 - 0.00% ✗ -
Aug 1, 2023 Drapkin Kimberlee C Director Neutral 52.5 - 0.00% ✗ -
Jul 19, 2023 Jul 21, 2023 Viney Joanne L. Director Neutral 52.5 - 0.00% ✗ -
Jul 19, 2023 Jul 21, 2023 Porteus Matthew Director Neutral 52.5 - 0.00% ✗ -
Jul 19, 2023 Jul 21, 2023 KARSEN PERRY A Director Neutral 52.5 - 0.00% ✗ -
Jul 19, 2023 Jul 21, 2023 JIMENEZ JOSEPH Director Neutral 52.5 - 0.00% ✗ -
Jul 19, 2023 Jul 21, 2023 Jerel Davis Director Neutral 52.5 - 0.00% ✗ -
Jul 19, 2023 Jul 21, 2023 Carlo Rizzuto Director Neutral 52.5 - 0.00% ✗ -
Jul 19, 2023 Jul 21, 2023 Bassan Abraham Director Neutral 52.5 - 0.00% ✗ -
Jul 19, 2023 Jul 21, 2023 Shah Smital Director Neutral 52.5 - 0.00% ✗ -
Jul 19, 2023 Jul 21, 2023 Hege Kristen Director Neutral 52.5 - 0.00% ✗ -
Feb 21, 2023 Feb 23, 2023 Young Alethia CFO Neutral 52.5 - 0.00% ✗ -
Feb 21, 2023 Feb 23, 2023 Lehrer-Graiwer Joshua CEO Neutral 52.5 - 0.00% ✗ -
Jan 6, 2023 EcoR1 Capital, LLC 10% Owner Neutral 52.5 - 0.00% ✗ -
Jun 21, 2022 Jun 22, 2022 Viney Joanne L. Director Neutral 52.5 - 0.00% ✗ -
Jun 21, 2022 Jun 22, 2022 Porteus Matthew Director Neutral 52.5 - 0.00% ✗ -
Jun 21, 2022 Jun 22, 2022 KARSEN PERRY A Director Neutral 52.5 - 0.00% ✗ -
Jun 21, 2022 Jun 22, 2022 JIMENEZ JOSEPH Director Neutral 52.5 - 0.00% ✗ -
Jun 21, 2022 Jun 22, 2022 Jerel Davis Director Neutral 52.5 - 0.00% ✗ -
Jun 21, 2022 Jun 22, 2022 Carlo Rizzuto Director Neutral 52.5 - 0.00% ✗ -
Jun 21, 2022 Jun 22, 2022 Bassan Abraham Director Neutral 52.5 - 0.00% ✗ -
Jun 21, 2022 Jun 22, 2022 Shah Smital Director Neutral 52.5 - 0.00% ✗ -
Jun 21, 2022 Jun 22, 2022 Hege Kristen Director Neutral 52.5 - 0.00% ✗ -
Apr 11, 2022 Apr 13, 2022 Samsara BioCapital, L.P. 10% Owner Buy 95.0 +424,464 5.26% ✗ $1.7M
Apr 11, 2022 Apr 13, 2022 Gutry Phil CHIEF BUSINESS OFFICER Buy 78.8 +5,000 1.70% ✗ $20.1K
Apr 1, 2022 Apr 5, 2022 Young Alethia CFO Neutral 52.5 - 0.00% ✗ -
Apr 5, 2022 Young Alethia CFO Neutral 52.5 - 0.00% ✗ -
Feb 16, 2022 Feb 18, 2022 Lehrer-Graiwer Joshua CEO Neutral 52.5 - 0.00% ✗ -
Feb 16, 2022 Feb 18, 2022 Gutry Phil CHIEF BUSINESS OFFICER Neutral 52.5 - 0.00% ✗ -
Jan 21, 2022 Jan 25, 2022 Samsara BioCapital, L.P. 10% Owner Buy 87.5 +123,000 1.55% ✗ $1.1M
Jan 19, 2022 Jan 21, 2022 Samsara BioCapital, L.P. 10% Owner Buy 85.0 +97,670 1.25% ✗ $888.7K
Dec 15, 2021 Dec 20, 2021 Samsara BioCapital, L.P. 10% Owner Buy 65.0 +22,329 0.29% ✗ $227.5K
Nov 22, 2021 Nov 24, 2021 Samsara BioCapital, L.P. 10% Owner Buy 92.5 +201,685 2.66% ✗ $2M
Oct 13, 2021 Oct 15, 2021 Samsara BioCapital, L.P. 10% Owner Buy 75.0 +50,800 0.67% ✗ $667.7K
Oct 6, 2021 Oct 8, 2021 Samsara BioCapital, L.P. 10% Owner Buy 87.5 +145,496 1.97% ✗ $2M
Jun 29, 2021 Jul 1, 2021 Versant Venture Capital VI, L.P. 10% Owner Buy 100.0 +180,000 11.78% ✗ $3.1M
Jun 29, 2021 Jul 1, 2021 Stultz Katherine V COO Neutral 52.5 - 0.00% ✗ -
Jun 29, 2021 Jul 1, 2021 Jerel Davis Director Buy 100.0 +180,000 11.78% ✗ $3.1M
Jun 29, 2021 Jul 1, 2021 Shah Smital Director Buy 95.0 +5,882 100.00% ✗ $100K
Jan 15, 2021 Jul 1, 2021 Gutry Phil CHIEF BUSINESS OFFICER Neutral 52.5 - 0.00% ✗ -
Jan 14, 2021 Jul 1, 2021 JIMENEZ JOSEPH Director Neutral 52.5 - 0.00% ✗ -
Jun 29, 2021 Jul 1, 2021 KARSEN PERRY A Director Neutral 52.5 - 0.00% ✗ -
Jan 16, 2021 Jul 1, 2021 Lehrer-Graiwer Joshua CEO Neutral 52.5 - 0.00% ✗ -
Jun 29, 2021 Jul 1, 2021 Samsara BioCapital, L.P. 10% Owner Buy 96.3 +500,000 7.21% ✗ $8.5M